Multiple Assemblies exist for SMTL entry 3v5q
Discovery of a selective TRK Inhibitor with efficacy in rodent cancer tumor models; X-RAY DIFFRACTION 2.20 Å

	SMTL ID 3v5q.1 Ligands CHLORIDE ION; 1-(3-{[(3Z)-2-oxo-3-(1H-pyrrol-2-ylmethylidene)-2,3-dihydro-1H-indol-6-yl]amino}phenyl)-3-[3-(trifluoromethyl)phenyl]urea Polypeptides NT-3 growth factor receptor Oligo-state monomer
	SMTL ID 3v5q.2 Ligands 1-(3-{[(3Z)-2-oxo-3-(1H-pyrrol-2-ylmethylidene)-2,3-dihydro-1H-indol-6-yl]amino}phenyl)-3-[3-(trifluoromethyl)phenyl]urea Polypeptides NT-3 growth factor receptor Oligo-state monomer